Abstract:Primary mitochondrial disease (PMD) is a large group of genetic disorders directly affecting mitochondrial function. Although next generation sequencing technologies have revolutionized the diagnosis of these disorders, biochemical tests remain essential and functional confirmation of the critical genetic diagnosis. While enzymological testing of the mitochondrial oxidative phosphorylation (OXPHOS) complexes remains the gold standard, oxygraphy could offer several advantages. To this end, we compared the diagn… Show more
“…Seventy-six percent (13/17) defects were encoded for by nuclear genes, 24% (4/17) by mtDNA. The phenotypic diagnosis of OXPHOS dysfunction in these fibroblast cell lines was previously characterised through enzymology and oxygraphy [ 11 ]. We included the PDH cell lines as a comparison group with non-OXPHOS related mitochondrial dysfunction.…”
Section: Resultsmentioning
confidence: 99%
“…Oxygraphy was performed as described previously [ 11 ] using the Oxygraph O2K from Oroboros instruments accordingly to previously published resources with a technical n of ≥3 [ 11 , 14 ]. Briefly, fibroblasts were harvested by trypsinisation from a T175 flask at a density of 80%, washed in PBS (phosphate buffered saline) and resuspended in Miro5 buffer to 20 million cells/mL.…”
Section: Materials Subjects and Methodsmentioning
confidence: 99%
“…Here, we applied tracing of U– 13 C-labeled glucose and U– 13 C-glutamine to determine the metabolic profile of OXPHOS dysfunction in genetic and pharmacological models of PMD [ [11] , [12] , [13] ]. Our results reveal a distinct and universal signature of OXPHOS deficiency with as main feature the depletion of aspartic acid.…”
“…Seventy-six percent (13/17) defects were encoded for by nuclear genes, 24% (4/17) by mtDNA. The phenotypic diagnosis of OXPHOS dysfunction in these fibroblast cell lines was previously characterised through enzymology and oxygraphy [ 11 ]. We included the PDH cell lines as a comparison group with non-OXPHOS related mitochondrial dysfunction.…”
Section: Resultsmentioning
confidence: 99%
“…Oxygraphy was performed as described previously [ 11 ] using the Oxygraph O2K from Oroboros instruments accordingly to previously published resources with a technical n of ≥3 [ 11 , 14 ]. Briefly, fibroblasts were harvested by trypsinisation from a T175 flask at a density of 80%, washed in PBS (phosphate buffered saline) and resuspended in Miro5 buffer to 20 million cells/mL.…”
Section: Materials Subjects and Methodsmentioning
confidence: 99%
“…Here, we applied tracing of U– 13 C-labeled glucose and U– 13 C-glutamine to determine the metabolic profile of OXPHOS dysfunction in genetic and pharmacological models of PMD [ [11] , [12] , [13] ]. Our results reveal a distinct and universal signature of OXPHOS deficiency with as main feature the depletion of aspartic acid.…”
“…Within the first year of life, she developed feeding difficulties, with relatively rapid feeding noted to easily promote vomiting, eventually necessitating the placement of a gastrostomy at 3 yr of age. Respiratory chain enzyme analysis in fibroblasts was normal ( Bird et al, 2019 ). From age 2 yr, she developed a progressive hardening of the skin, a change in facial appearance due to loss of fat tissue, and areas of panniculitis involving the lower limbs.…”
Mitochondrial DNA (mtDNA) has been suggested to drive immune system activation, but the induction of interferon signaling by mtDNA has not been demonstrated in a Mendelian mitochondrial disease. We initially ascertained two patients, one with a purely neurological phenotype and one with features suggestive of systemic sclerosis in a syndromic context, and found them both to demonstrate enhanced interferon-stimulated gene (ISG) expression in blood. We determined each to harbor a previously described de novo dominant-negative heterozygous mutation in ATAD3A, encoding ATPase family AAA domain–containing protein 3A (ATAD3A). We identified five further patients with mutations in ATAD3A and recorded up-regulated ISG expression and interferon α protein in four of them. Knockdown of ATAD3A in THP-1 cells resulted in increased interferon signaling, mediated by cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Enhanced interferon signaling was abrogated in THP-1 cells and patient fibroblasts depleted of mtDNA. Thus, mutations in the mitochondrial membrane protein ATAD3A define a novel type I interferonopathy.
“…Within the first year of life she developed feeding difficulties, with relatively rapid feeding noted to easily promote vomiting, eventually necessitating the placement of a gastrostomy at three years of age. Respiratory chain enzyme analysis in fibroblasts was normal (Bird et al, 2019). From age two years she developed a progressive hardening of the skin, and a change in facial appearance due to loss of fat tissue, and areas of panniculitis involving the lower limbs.…”
Mitochondrial DNA (mtDNA) has been suggested to drive immune system activation, but the induction of interferon signaling by mtDNA has not been demonstrated in a Mendelian mitochondrial disease. We initially ascertained two patients, one with a purely neurological phenotype, and one with features suggestive of systemic sclerosis in a syndromic context, and found them both to demonstrate enhanced interferon-stimulated gene (ISG) expression in blood. We determined each to harbor a previously described de novo dominant-negative heterozygous mutation in ATAD3A, encoding ATPase family AAA domain-containing protein 3A (ATAD3A). We identified five further patients with mutations in ATAD3A, and recorded up-regulated ISG expression and interferon alpha protein in four of them. Knockdown of ATAD3A in THP-1 cells resulted in increased interferon signaling, mediated by cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Enhanced interferon signaling was abrogated in THP-1 cells and patient fibroblasts depleted of mtDNA. Thus, mutations in the mitochondrial membrane protein ATAD3A define a novel type I interferonopathy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.